ABOUT THE IAC
Principal Staff
Board of Directors
Sponsoring Organizations
Policies & Procedures

THE IAC DIVISIONS

ACCREDITATION
About the Process
Why Accreditation Counts
The Agreement
Accreditation Fees
Accreditation in the News

IAC NEWSLETTER

EXHIBIT SCHEDULE

WEB EVENTS

CONTACT THE IAC

home

IAC Newsletter

Effective January 1, 2009, those laboratories applying for accreditation solely in Nuclear Cardiology (i.e., radionuclide myocardial perfusion [RMPI], equilibrium radionuclide angiography [ERNA], or cardiac PET) will no longer be required to follow the random selection criteria when submitting the RMPI case studies. Laboratories will be required to submit five (5) complete RMPI studies following the guidelines discussed below. In addition to the five cases, laboratories will be required to submit two abnormal reports (without any images or clinical data) from each interpreting physician listed in the application.

All cases must be selected from studies performed two months prior to the expected submission of the application. For example, if a laboratory intends to submit the application on January 1, the cases can be chosen from the beginning of November through December 31.

Cases are selected as follows: Only one study may be normal. There must be at least one study demonstrating myocardial infarction, at least one study demonstrating ischemia, and at least one study demonstrating significant regional or global wall motion abnormality. The remaining studies must abnormal and can demonstrate any of the pathologies listed above. At least one of the five cases must be an exercise stress study and one must be a pharmacologic stress study. In addition, the cases must have been interpreted by as many different physicians as possible, performed by different technologists and if more than one camera is present in the laboratory, cases must be selected from each camera in use. For instance, if there are five interpreting physicians in the laboratory then each case study must be from a different physician or if there are two interpreting physicians in the laboratory, three cases studies must be from one physician and two case studies from the other physician. For more information see www.icanl.org.

• 5 total case studies:
  1 normal study
  1 ischemic study
  1 infarction study
  1 wall motion abnormality study
  At least 1 of the five must be an exercise stress study
  At least one of the five must be a pharmacologic stress study

***